Vanguard Group Inc Eli Lilly & CO Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Vanguard Group Inc holds 73,773,467 shares of LLY stock, worth $58.7 Billion. This represents 1.2% of its overall portfolio holdings.
Number of Shares
73,773,467
Previous 73,859,008
0.12%
Holding current value
$58.7 Billion
Previous $66.9 Billion
2.26%
% of portfolio
1.2%
Previous 1.31%
Shares
15 transactions
Others Institutions Holding LLY
# of Institutions
4,011Shares Held
751MCall Options Held
8.27MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$77.2 Billion0.0% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$52.4 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$40.9 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$27 Billion1.24% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD20.9MShares$16.7 Billion2.13% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $757B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...